Related Experiment Video
Updated: Jun 23, 2025

05:00
Using a Chemical Biopsy for Graft Quality Assessment
Published on: June 17, 2020
5.2K
Competing Risks Analysis of Kidney Transplant Waitlist Outcomes: Two Important Statistical Perspectives
Jeffrey J Gaynor1, Giselle Guerra2, Rodrigo Vianna1
1Department of Surgery, Miami Transplant Institute, University of Miami Miller School of Medicine; Miami, Florida, USA.
Kidney International Reports
|June 20, 2024
Summary
Competing risks analysis in clinical epidemiology aims to understand patient outcomes and risks. Accurate analysis of kidney transplant waiting list events requires cause-specific hazard models and appropriate cumulative incidence functions, avoiding biased methods like "one minus Kaplan-Meier".
Area of Science:
- Clinical Epidemiology
- Biostatistics
- Transplant Surgery
Background:
- Competing risks analysis is crucial in clinical epidemiology for understanding patient outcomes.
- Two primary goals include identifying etiologic associations and assessing differences in cause-specific patient risk.
- Kidney transplant waiting lists present a complex scenario with multiple distinct outcomes.
Purpose of the Study:
- To elucidate the goals of competing risks analysis in clinical epidemiology.
- To highlight the application of these models in deceased donor kidney transplant (DDKT) candidate analysis.
- To emphasize the importance of understanding cause-specific hazards as foundational for cumulative incidence functions (CIFs).
Main Methods:
- Utilizing cause-specific hazard models to understand associations between predictors and outcomes.
- Employing cause-specific subdistribution hazard models for analyzing differences in cause-specific patient risk.
- Discussing the estimation of cause-specific conditional failure probability for transplant waiting times.
Main Results:
- Cause-specific hazards are essential building blocks for cumulative incidence functions (CIFs).
- Subdistribution hazard ratios cannot be fully understood without knowledge of cause-specific hazards.
- The "one minus Kaplan-Meier" approach is inappropriate and produces biased estimates for competing risks.
Conclusions:
- Accurate competing risks analysis requires understanding both cause-specific hazards and appropriate CIF estimators.
- The analysis of kidney transplant candidates necessitates careful consideration of competing events.
- Clinicians must avoid biased estimation methods to ensure reliable patient risk assessment.
Related Concept Videos
Tissue Transplantation
356
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
356
Bone Marrow Sampling and Transplants
324
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
324

